.png){kind=icon}
.png){kind=icon}
Return
Low-dose chemotherapy remodels hepatic immune landscape and potentiates antitumor response to immune checkpoint blockade in cholangiocarcinoma
.png){kind=icon}
PRE
AI
L
L
H
L
K
L
S
W
Y
Z
L
J
W
L
S
S
C
H
Y
Y
DOI：10.1097/HEP.0000000000001735.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background and Aims:While gemcitabine/cisplatin (GC) combined with anti-PD-L1 is a first-line regimen for advanced intrahepatic cholangiocarcinoma (ICC), efficacy remains limited and toxicity significant, highlighting the need to optimize the therapeutic strategy. We sought to investigate whether low-dose GC (LDGC) could unleash anti-PD-L1-mediated antitumor immunity along with reduced toxicity.Approach and Results:Multiple preclinical ICC mouse models were used to assess the antitumor efficacy and toxicity of LDGC combined with anti-PD-L1. Mechanisms were investigated via single-cell RNA sequencing, flow cytometry, and in vivo/vitro functional assays. Clinical correlation was evaluated in patient-derived tumor fragments and a pilot clinical trial in ICC patients. LDGC combined with anti-PD-L1 treatment efficiently improved tumor immune microenvironment (TIME) through reducing immunosuppressive SPP1+ tumor-associated macrophages (TAMs) while promoting CD8+ T-cell infiltration and cytotoxicity. LDGC reprograms the interplay between STAT1 and STAT3 transcriptional pathways in TAMs, thereby reducing SPP1 expression and weakening the inhibitory effect of the SPP1-VLA-4 signaling axis on CD8+ T cells, ultimately enhancing T-cell cytotoxicity and sensitizing antitumor response to anti-PD-L1. Furthermore, the ICC patients exhibited superior response and tolerance to LDGC combined with immunotherapy.Conclusions:This study highlights that LDGC remodels the immunosuppressive microenvironment and potentiates anti-PD-L1 therapy, providing a rational regimen for ICC.
Keywords:
immunotherapy
intrahepatic cholangiocarcinoma
low-dose chemotherapy
tumor microenvironment
Journal
IF:
15.8
Papers:
2.0W
Citations:
7.2W
Organization
Cited Papers